Long-term Tripotent Differentiation Capacity of Human Neural Stem (NS) Cells in Adherent Culture
Overview
Molecular Biology
Neurology
Authors
Affiliations
Stem cell lines that provide a renewable and scaleable supply of central nervous system cell types would constitute an invaluable resource for basic and applied neurobiology. Here we describe the generation and long-term expansion of multiple human foetal neural stem (NS) cell lines in monolayer culture without genetic immortalization. Adherent human NS cells are propagated in the presence of epidermal growth factor (EGF) and fibroblast growth factor 2 (FGF2), under which conditions they stably express neural precursor markers and exhibit negligible differentiation into neurons or glia. However, they produce astrocytes, oligodendrocytes, and neurons upon exposure to appropriate differentiation factors. Single cell cloning demonstrates that human NS cells are tripotent. They retain a diploid karyotype and constant neurogenic capacity after over 100 generations. In contrast to human neurospheres, we observe no requirement for the cytokine leukaemia inhibitory factor (LIF) for continued expansion of adherent human NS cells. Human NS cells can be stably transfected to provide reporter lines and readily imaged in live monolayer cultures, creating the potential for high content genetic and chemical screens.
U K, Gao L, Zhang H, Ji Z, Lin J, Peng S Cell Death Differ. 2025; .
PMID: 40033066 DOI: 10.1038/s41418-025-01470-2.
Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models.
Correia C, Calado S, Matos A, Esteves F, De Sousa-Coelho A, Campinho M Cells. 2025; 14(4).
PMID: 39996764 PMC: 11854129. DOI: 10.3390/cells14040292.
Human stem cell models to unravel brain cancer.
Dave B, Tailor J BMC Cancer. 2024; 24(1):1465.
PMID: 39609728 PMC: 11603633. DOI: 10.1186/s12885-024-13187-5.
Modelling quiescence exit of neural stem cells reveals a FOXG1-FOXO6 axis.
Ferguson K, Blin C, Garcia-Diaz C, Bulstrode H, Bressan R, McCarten K Dis Model Mech. 2024; 17(12).
PMID: 39499086 PMC: 11625887. DOI: 10.1242/dmm.052005.
A novel TAp73-inhibitory compound counteracts stemness features of glioblastoma stem cells.
Villoch-Fernandez J, Martinez-Garcia N, Martin-Lopez M, Maeso-Alonso L, Lopez-Ferreras L, Vazquez-Jimenez A Mol Oncol. 2024; 19(3):852-877.
PMID: 39090849 PMC: 11887682. DOI: 10.1002/1878-0261.13694.